Personalized BPH Treatment: Customized Care with Alpha-Blockers for Optimal Results

H2 tag- SEO Purpose

5ARIs: 5-alpha-reductase inhibitors; BPH: Benign prostatic hyperplasia; ED: Erectile dysfunction; IFIS: Intraoperative floppy iris syndrome; IPSS: International prostate symptom score.

Alfoo logo
Alpha-blockers are key in management of BPH, but they come with a downside: Potential sexual dysfunction.
Personalizing treatment based on patient characteristics such as symptom severity, age, comorbidities, and sexual status is crucial for improved treatment outcomes.
Carefully selecting the most suitable pharmacological approach for each patient can significantly enhance the patient’s overall quality of life.
An Indian consensus group proposed a clinical algorithm that provides a comprehensive approach, from watchful waiting to medical treatments with alpha-blockers.
Optimizing BPH Management: The Indian BPH Management Algorithm
Alfuzosin offers a better option for BPH treatment in sexually active males due to its lower risk of ejaculatory dysfunction compared to other alpha-blockers.

Alfuzosin offers a better option for BPH treatment in sexually active males due to its lower risk of ejaculatory dysfunction compared to other alpha-blockers.1–3

Alfoo logo

Alfoo-Improved Pharmacokinetics

ALFOO, containing  Alfuzosin molecule, is Anti-BPH which helps in treatment of LUTS due to BPH in Young Sexually Active Male in 40-60 year old age group

Alfoo banner